Restriction of 6 PFASs progresses

ECHA’s risk assessment and socio-economic committees agree with restriction proposal for 6 per- and polyfluorinated substances; CLP classifications adopted for four other FCM-relevant substances

REACH nano revisions adopted

EU Commission adopts revision of information requirements for nanomaterials to be provided in REACH registration dossiers; new rules apply from January 1, 2020

ECHA: Microplastics likely end up in soil and freshwater

ECHA’s risk assessment finds intentionally added microplastics more likely to accumulate in terrestrial and freshwater environments than in oceans

Opinion: SVHC database not ‘crazy’

NGO ChemSec positively comments on the SVHC database being developed by European Chemistry Agency, calls on industry to invest in transparency and ‘think outside of the box’

ECHA: Registrations must ‘reflect the most up-to-date knowledge’

European Chemicals Agency reminds companies of legal obligation to review and update REACH registration dossiers ‘when new information becomes available’

Data requirements for SVHC database clarified

Database of SVHCs as proposed by ECHA will oblige companies to only provide data already required under REACH; additional data on article identity and SVHC concentrations voluntary

Discussing database on SVHCs in products

Manufacturers criticize ECHA’s proposal for database of SVHCs in products; recycling industry welcomes the idea but is concerned about lack of coverage for products already marketed; ECHA to hold a workshop on SVHC database on October 22-23, 2018

100 substances in CoRAP for 2019-2021

ECHA publishes list of 96 substances planned to be evaluated by EU Member States in 2019-2021 under the Community Rolling Action Plan (CoRAP)

Webinar on SIN list

ChemSec hosts webinar explaining its SIN List on October 3, 2018; registration now open

Regulatory identification of BPA as endocrine disruptor

Special issue of Molecular and Cellular Endocrinology addresses regulatory identification of bisphenol A as endocrine disruptor, summarizes evidence for endocrine-mediated adverse effects on estrous cycle, mammary gland development, neurobehavior, metabolism